
Beyond the Prescription: How Bullying and Social Networks Affect Device Use in Youth with Type 1 Diabetes
A new study reveals that for lower-income youth and youth of color with Type 1 diabetes, having access to insulin pumps and CGM devices is only part of the challenge. Social barriers at school and limited connections to other Type 1 families can make it harder to actually use these tools.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Racial and socioeconomic disparities in Type 1 diabetes device use go beyond who gets prescribed pumps and CGMs—they also include who faces barriers once they have them
- Lower-income youth and youth of color report more bullying and victimization at school related to their devices, sometimes leading them to stop using them
- Many lower-income and youth of color with Type 1 diabetes have more connections to people with Type 2 diabetes than to others with Type 1, which can reinforce stigma and limit peer support
- Social connection matters: lacking access to other families managing Type 1 reduces the 'social capital' and peer understanding that help youth stick with their devices
Access Is Not Enough
Getting an insulin pump or continuous glucose monitor (CGM) is a major step in Type 1 diabetes management—but only if a young person can actually use it every day, at school, and in public. A new study of 50 youth with Type 1 diabetes and 56 of their caregivers reveals that racial and socioeconomic disparities don't stop at prescription. Instead, they shape whether young people feel safe and supported enough to keep using these devices.
Researchers compared the experiences of higher-income, primarily White youth with Type 1 diabetes to those of lower-income youth, and youth of color—predominantly Latinx and Black. While both groups faced some similar challenges, the study uncovered two striking differences that highlight hidden inequities in device use.
Bullying and Fear at School
Lower-income youth and youth of color with Type 1 diabetes reported significantly more fear and bullying related to their devices at school. This isn't a minor inconvenience—the study found that bullying and victimization can lead young people to stop using their pumps or CGMs altogether.
When a young person chooses to discontinue their device because of bullying or social rejection, they lose the health benefits that device provides. This creates a real gap in care quality based not on medical need, but on social environment and safety.
The Power of Social Networks
The second major finding involved social connections. Lower-income youth and youth of color with Type 1 diabetes reported having fewer connections to other families managing Type 1 diabetes. Instead, they had more connections to people with Type 2 diabetes.
This matters because it shapes how others—and sometimes the youth themselves—perceive their disease. When peers and community members mostly know about Type 2 diabetes, they may assume that a young person with diabetes has Type 2. This misunderstanding carries significant stigma and misconceptions. More importantly, it means these young people miss out on the support, practical advice, and solidarity that comes from connecting with other families living with Type 1 diabetes specifically.
Researchers called this missing connection a loss of 'diabetes-related social capital'—the knowledge, support, and understanding within a community that can make managing a condition easier and less isolating.
What This Means
This research shows that health inequities in device use are about more than money or access to doctors. They involve bullying, social isolation, stigma, and the simple fact that some young people have communities of support while others don't.
Addressing these disparities will require attention to the social environment—school safety and inclusion, community support networks, and ensuring that all youth with Type 1 diabetes can connect with peers who understand their condition. Device access is necessary, but it's not sufficient on its own.
Evidence label
Source: SSM. Qualitative research in health. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Living With T1DWhat Predicts Success With Automated Insulin Delivery? New Data Points to Baseline Control
- Living With T1DNew Research Tests Whether Lifestyle Changes Can Help Control High Blood Pressure in Medicated Patients
- Living With T1DArtificial Pancreas Systems Keep Working Well for Kids Over 3 Years, Real-World Study Shows
- Living With T1DTwo Insulin Pump Algorithms Tested Against Surprise Meals: What Worked Best
- Living With T1DAutomated Insulin Delivery During Pregnancy: What Women With Type 1 Diabetes Need to Know
- Living With T1DThe Surprising Link Between Caregiver Anxiety and Blood Sugar Control in Teens With Type 1 Diabetes